(Q52519232)

2 May 2018

title

Somatic overgrowth associated with overexpression of insulin-like growth factor II. (English)

1 reference

2 May 2018

1 reference

1 reference

1

1 reference

2 May 2018

author name string

Becroft DM

2

1 reference

2 May 2018

Taniguchi T

3

1 reference

2 May 2018

Woods CG

4

1 reference

2 May 2018

Reeve AE

5

1 reference

2 May 2018

language of work or name

English

0 references

publication date

1 March 1996

1 reference

2 May 2018

published in

Nature Medicine

1 reference

2 May 2018

volume

2

1 reference

2 May 2018

page(s)

311-316

1 reference

2 May 2018

issue

3

1 reference

2 May 2018

https://scigraph.springernature.com/pub.10.1038/nm0396-311

exact match

0 references

cites work

Disruption of imprinting caused by deletion of the H19 gene region in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

Relaxation of imprinted genes in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

Paternal origin of 11p15 duplications in the Beckwith-Wiedemann syndrome. A new case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumour and gigantism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

Uniparental paternal disomy in a genetic cancer-predisposing syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

Expression of insulin-like growth factor-II transcripts in Wilms' tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Mono- and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Mosaic uniparental disomy in Beckwith-Wiedemann syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution.

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Somatic mosaicism for partial paternal isodisomy in Wiedemann-Beckwith syndrome: a post-fertilization event

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Chromosome 11 uniparental isodisomy predisposing to embryonal neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Molecular analysis of a patient with Beckwith-Wiedemann syndrome, rhabdomyosarcoma and renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Epigenetic lesions at the H19 locus in Wilms' tumour patients

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Sonographic measurements and appearance of normal kidneys in children

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Molecular diagnosis of the Prader-Willi and Angelman syndromes by detection of parent-of-origin specific DNA methylation in 15q11-13

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Polymerase chain reaction (PCR) for detection of APal polymorphism at the insulin like growth factor II gene (IGF2)

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Allelic methylation of H19 and IGF2 in the Beckwith-Wiedemann syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Histopathology and prognosis of Wilms tumorResults from the first national wilms' tumor study

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Genetic mosaicism in normal tissues of Wilms' tumour patients

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Molecular definition of the 11p15.5 region involved in Beckwith-Wiedemann syndrome and probably in predisposition to adrenocortical carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by altered imprinting pattern in the IGF2-H19 domain.

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

The Wiedemann-Beckwith syndrome: pedigree studies on five families with evidence for autosomal dominant inheritance with variable expressivity

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Dominant inheritance of Wiedemann-Beckwith syndrome: further evidence for transmission of "unstable premutation" through carrier women

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Tight linkage between the Beckwith-Wiedemann syndrome and a microsatellite marker for the TH locus.

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Complete and incomplete forms of Beckwith-Wiedemann syndrome: their oncogenic potential

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Congenital pancreatoblastoma in Beckwith-Wiedemann syndrome: an emerging association

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Insulin-like growth factors and their binding proteins

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines.

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-311

7 January 2021

Identifiers

DOI

10.1038/NM0396-311

1 reference

2 May 2018

PubMed ID

8612230

1 reference

2 May 2018